VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1018573
Sex: M
Age:
State: GA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: Blood work; Result Unstructured Data: Test Result:Unknown results; Comments: Lab test: Consumer stated, "Blood work but I do not have the records right now".

Allergies:

Symptoms: had a feeling like taste liberty; Diarrhea; hemorrhoids; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: unknown) via an unspecified route of administration on 22Jan2021 at a single dose for COVID-19 immunization. Medical history included diabetic. Concomitant medications were not reported. The patient stated he took the vaccine shot, Covid 19 and he suddenly got diarrhea, hemorrhoids that was on 22Jan2021 on the Friday. Then he experienced some problem with it, the next day the 23Jan2021 it was Saturday. Again he woke up this morning (on 25Jan2021) which was Monday and had a feeling like taste liberty. Asked if that was probably the side effect or a reaction to be treated. Patient stated blood work but he did not have the records right now. Patient stated he took bismuth subsalicylate (PEPTO BISMOL) and a zinc sulfate (PEPTIN, reported as Kill Peptin). He took bismuth subsalicylate Pepto Bismol. It was for the fluid of the stomach and diarrhea. It was called Pepto Bismol. He did not how to spell it. The events were considered as non-serious. The outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018574
Sex: U
Age:
State:

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: covid; Result Unstructured Data: Test Result:diagnosed with covid

Allergies:

Symptoms: I received my first Pfizer covid vaccine in Dec and 3 days later was diagnosed with covid; I received my first Pfizer covid vaccine in Dec and 3 days later was diagnosed with covid; This is a spontaneous report from a contactable physician (patient). A patient of unspecified age and gender received the 1st dose of bnt162b2 (BNT162B2) at single dose in Dec2020 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the 1st dose vaccine in Dec2020 and 3 days later was diagnosed with Covid on an unknown date. The patient underwent lab tests and procedures which included Sars-cov-2 test: diagnosed with cCvid in Dec2020. Patient received the monoclonal antibody infusion and has recovered. Patient knew he/she needed to wait 90 days from the MCA infusion before having the second vaccination. Patient queried whether it would be recommended to start the series over with two additional vaccines since the timing between the first and second vaccines will be so long. Information on the lot/batch number has been requested.; Sender's Comments: The COVID-19 infection occurred 3 days after the injection of suspect vaccine BNT162B2. No complete effect can be achieved against the target disease due to the short time interval. The COVID-19 is more likely pre-existing condition, unrelated to suspect vaccine BNT162b2.

Other Meds:

Current Illness:

ID: 1018576
Sex: M
Age:
State: NY

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210125; Test Name: COVID test; Test Result: Negative ; Comments: via Nasal Swab

Allergies:

Symptoms: Low grade fever; severe chills and shaking; severe chills and shaking; severe joint pain for 5 hours; sweats; Post fever fatigue; other vaccine same date vaccine date=21Jan2021; other vaccine same date vaccine date=21Jan2021; This is a spontaneous report from a contactable other HCP (patient). A 65-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Jan2021 13:00 at single dose in right arm for COVID-19 immunisation. The patient medical history was not reported. There were no known allergies. Concomitant medication included irbesartan. 3 days post-vaccine on 24Jan2021 19:00, the patient experienced low grade fever, severe chills and shaking, severe joint pain for 5 hours and then sweats, post fever fatigue. No treatment received for these events, and these events were recovered on Jan2021. The patient received other vaccine on the same date 21Jan2021. The patient received COVID test post vaccination via Nasal Swab on 25Jan2021, COVID test result was Negative. Information on the Lot/Batch number has been requested.

Other Meds: IRBESARTAN

Current Illness:

ID: 1018578
Sex: F
Age:
State: NY

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: blood work; Result Unstructured Data: Test Result:normal

Allergies:

Symptoms: muscle pain in her arm where she received the injection; cough; hoarseness in her voice; clearing of the throat; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; unknown lot number and expiration date), via an unspecified route of administration on 22Jan2021 at a single dose for covid-19 immunization. Medical history included has ongoing allergies and has to take an "allergy pill" every day for this condition, diabetes and hypothyroidism. Concomitant medication included levothyroxine, ertugliflozin pidolate (STEGLATRO), loratadine, montelukast, metformin, atorvastatin, lisinopril, colecalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12), dulaglutide (TRULICITY) and ongoing allergy pill. She reported that she received her vaccine in a mass Covid vaccination. The reporter stated that she developed muscle pain in her arm where she received the injection, which she states that she understands this is a commonly reported side effect. She also developed a cough, hoarseness in her voice, and noticed that the cough was worse when she went to bed. She mentioned that her cough started on Wednesday, she felt like it was little bit worse on last night (unspecified date), than it was on Saturday, so she means it was only Sunday after that [pending clarification]. The reporter was heard clearing her throat multiple times on the phone during the conversation. She would like to know if the cough, hoarseness and clearing of the throat are commonly reported symptoms. The patient was informed that the injection side pain was reported last on average between 1-3 days. Per the EUA Prescribing Information, "Across both age groups, the mean duration of pain at the injection site after Dose 2 was 2.5 days" and that we did not have information on how long her mild respiratory symptoms may last and referred her to her HCP. The patient was encouraged to contact her healthcare professional if her symptoms did not go away or if they became worrisome and she verbalized understanding. No treatment was received for the adverse events. The patient underwent lab tests and procedures which included blood work showed normal on 15Jan2021. The outcome of the event cough was not recovered while the outcome of the other events was unknown. Information about Batch/Lot number has been requested.

Other Meds: LEVOTHYROXINE; STEGLATRO; LORATADINE; MONTELUKAST; METFORMIN; ATORVASTATIN; LISINOPRIL; VITAMIN D [COLECALCIFEROL]; VITAMIN B12 [CYANOCOBALAMIN]; TRULICITY

Current Illness: Allergy (she also has allergies and has to take an "allergy pill" every day for this condition)

ID: 1018579
Sex: F
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizziness; Sudden worsening of vision; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3247), via an unspecified route of administration (left arm), on 19Jan2021 11:15, at single dose, for covid-19 immunization. The patient has no medical history. Concomitant medications included calcium citrate and, probiotics. The patient previously took tamoxifen and experienced allergies. The patient experienced dizziness starting on 22Jan2021 and worsening on 23Jan2021. The patient also experienced sudden worsening of vision on 22Jan2021. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the events. At the time of the report, the patient was recovering from the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.

Other Meds: CALCIUM CITRATE; PROBIOTICS

Current Illness:

ID: 1018580
Sex: F
Age:
State: WI

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: shortness of breath; Several episodes of racing heart; chest pressure; fatigue; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at arm right on 04Jan2021 at 15:30 at single dose for COVID-19 immunization. The patient medical history included allergies: shellfish from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 04Jan2021 at 15:45, the patient experienced several episodes of racing heart, shortness of breath, chest pressure and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 11Jan2021. Therapeutic measures were taken as a result of the events and included treatment with albuterol. The patient outcome of the event was recovering. The information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 1018582
Sex: F
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: feeling pretty bad/ feel awful; she doesn't want to eat; her back hurts; she's irritable; depressed; pain in the injection site; joint pain; muscle pain; fatigue; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: EL3247), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunization. The patient thinks she could have COVID last Mar2020. She was not sure because her doctor's office was close for around a month and she couldn't get tested. There were no concomitant medications. On that day, 19Jan2021, after she received the vaccine she started feeling pain in the injection site, joint pain, muscle pain and fatigue. On 25Jan2021, she was feeling pretty bad, she doesn't want to eat, her back hurts, she's irritable and depressed. The patient would like to know if these side effects could be associated with the vaccine in someone who had the virus. She felt awful and she felt like she has gone right back to where she was 8 months ago, 10 months ago and started over with fatigue and everything. It was awful. She thinks she could have had COVID in Mar2020 and the symptoms she was having now, she had then and when she has had basically the whole time and that would just come back worse. There was no treatment received for the events. The outcome for the events was unknown.

Other Meds:

Current Illness:

ID: 1018583
Sex: F
Age:
State:

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm from which she could not raise arm; Dehydration; This is a spontaneous report from a contactable consumer. A 21-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in the right arm, on 22Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant. The patient had no other vaccine administered in four weeks. The patient was not diagnosed with covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 22Jan2021, the patient experienced sore arm from which she could not raise arm above shoulder and dehydration. The events were not treated. Outcome of the events was recovered on unspecified date in Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018585
Sex: F
Age:
State: CT

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: developed a pink rash with itchiness around the injection site; developed a pink rash with itchiness around the injection site; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL9263), via an unspecified route of administration on 22Jan2021 at single dose (upper left arm) for COVID-19 immunisation. Medical history included acid reflux and high blood pressure. Concomitant medications included metoprolol succinate (TOPROL XL), amlodipine, pantoprazole and an unspecified high blood pressure medication. The patient reported that she received the first dose of COVID-19 vaccine on Friday 22Jan2021 and she stated that she has no reaction at all the day she received the injection. She reported that 24 hours later, on 23Jan2021, she developed a pink rash with itchiness around the injection site and it was about an inch and a half in diameter. She stated that it lasted about 24 hours and was now fading and getting better. Patient stated that she would not call the them critical side effects, they were minor side effects. Patient described them as pink itching rash around the injection site. It was basically 24 hours it lasted. It started 24 hours after the injection and lasted 24 hours before it started fading, the patient still have it but it's fading away now and patient confirmed that the events were improving. The patient did not received therapy for the events. She was concerned that if she receives the second dose of the COVID-19 vaccine it could be worse and wants to know if she should receive the second dose. Patient was worried that in 3 weeks she will take the next second dose she might have an increased side effects. Outcome of events was recovering.

Other Meds: TOPROL XL; AMLODIPINE; PANTOPRAZOLE

Current Illness:

ID: 1018586
Sex: F
Age:
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe Nausea; severe headache; vomited once; slight dizziness; Dose 1 given on 18Dec2020 and Dose 2 on 15Jan2021 (Day 29); Dose 1 given on 18Dec2020 and Dose 2 on 15Jan2021 (Day 29); This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248), intramuscular on 15Jan2021 06:30 at a single dose on right arm for COVID-19 immunization. Medical history included fistula repair resulting into placement of neurostimulator. The patient was not pregnant at the time of vaccination. No known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included ibuprofen (IBUPROFEN), biotin (BIOTIN) and Nature's Made multivitamins. The patient previously received first dose of BNT162B2 on 18Dec2020 for COVID-19 immunization (lot number: EK5730, administration time: 06:30 AM, route: Intramuscular, vaccine location: Right arm, dose number: 1). No other vaccines received 4 weeks prior to vaccination. On 16Jan2021 09:00, the patient experienced severe nausea, severe headache, vomiting once and slight dizziness. No treatment was given for the adverse events. The patient has not been tested for COVID post vaccination. The patient recovered from severe nausea, severe headache, vomiting once and slight dizziness on Jan2021.

Other Meds: IBUPROFEN; BIOTIN

Current Illness:

ID: 1018588
Sex: M
Age:
State: AR

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: Blood pressure; Result Unstructured Data: Test Result:in the 80's over 50's; Test Date: 202101; Test Name: Blood pressure; Result Unstructured Data: Test Result:fluctuated; Test Name: uric acid levels; Result Unstructured Data: Test Result:high; Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:102.2 Fahrenheit; Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:98.8 Fahrenheit; Test Date: 20210116; Test Name: Covid-19 virus test; Test Result: Positive

Allergies:

Symptoms: COVID-19 virus test positive; COVID-19 virus test positive; Blood pressure fluctuation; This is a spontaneous report from a contactable consumer reporting for himself and from another consumer. A 57-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EK4176), via an unspecified route of administration in the right arm, on 05Jan2021 at 14:10, at single dose, for COVID-19 immunisation. Medical history included ongoing gout and ongoing blood pressure high. Concomitant medications included allopurinol (unknown manufacturer) from 2008 to an unknown date and from an unknown date to ongoing for gout, lisinopril (unknown manufacturer) from an unspecified date and ongoing for blood pressure high at 40 mg daily, an unspecified drug for blood pressure high from Dec2020 at 5 mg and an unspecified anti-inflammatory. The patient previously took allopurinol from 2008 for gout and experienced abdominal pain upper so the drug was stopped on unknown date but his uric acid levels get high and he had to go back on it again. The patient experienced COVID-19 virus test positive (medically significant) on 16Jan2021 with outcome of unknown and blood pressure fluctuation in Jan2021 with outcome of unknown. It was reported that the only symptom he had on 13Jan2021 at first was a crash in his blood pressure. It was in the 80's over 50's. After that he had a fever of 102.2 F on 13Jan2021 for which he took two Tylenol. On 13Jan2021 at 09:30 PM his temperature was back down to 98.8 F. He has not had anymore fever. He has not had any other symptoms since. His blood pressure fluctuated but they have made some changes with his medication. The patient underwent lab tests and procedures which included blood pressure: in the 80's over 50's on 13Jan2021, blood pressure: fluctuated in Jan2021, uric acid levels: high on unspecified date, body temperature: 102.2 F on 13Jan2021, body temperature: 98.8 F on 13Jan2021, COVID-19 virus test: positive on 16Jan2021. Therapeutic measures were taken as a result of the events.

Other Meds: ALLOPURINOL; LISINOPRIL

Current Illness: Blood pressure high; Gout

ID: 1018589
Sex: F
Age:
State: AR

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: weight; Result Unstructured Data: Test Result:Lost

Allergies:

Symptoms: Sore arm; lost a bunch when she had sugery; Tremors in her hands/hands started shaking non-stop; Tremors in her hands/hands started shaking non-stop; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on 21Jan2021 at 10:40 at single dose for COVID-19 immunization. The relevant medical history included asthma, tremor (Tremors that runs on her mother's side of the family), neuropathy of hands and arms, high cholesterol, thyroid, neuropathy, vascular gait disorder, cervical stenosis operation from 2018. Concomitant medications included painkiller for neuropathy and unspecified medicines for high cholesterol, thyroid. She stated she received the first dose on 21Jan2021 and experienced tremors in her hands starting the following day. She stated that Friday her hands started shaking non-stop and had done that since then. She also reported having a sore arm. She had occasional tremors that didn't last very long. Since COVID-19 Vaccine had had nonstop shaking of hands since around Friday. Primary care doctor didn't treat her. Went to a pain center and neurologist. No further details provided. Tried to report online, but there were too many questions so she opted out. Does kind of get better if she is real still and lays down, but it still shakes. Never had this before. The patient stated that Friday or Saturday she didn't remember exactly when, sometimes they shake but not very long but this was like nonstop and it's a much more aggressive shaking. She hoped she could get the second one because she wanted the protection. She was not sure of her weight because she lost a bunch when she had surgery but she was about 115. When probed for treatment, she stated that it went away it was a day or so after but the hands were shaking and it's very intense shaking and it's going on and it's not stopping. She didn't have anything for it. It's never been like this before. The outcome of the event tremors in her hands/hands started shaking non-stop was not recovered, while other events were unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018590
Sex: F
Age:
State: AZ

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lump nodes swell; Feeling unwell; Nausea; Headaches; Dizziness; Weakness; Injection site pain; This is a spontaneous report from a contactable healthcare professional (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1283; Expiration date was not reported) on 24Jan2021 (08:00) at a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the school/student health clinic. Medical history included asthma. There were no concomitant medications. The patient was not pregnant at the time of vaccination. On 24Jan2021 (14:00), the patient had "lump" nodes swelling; was feeling unwell; had nausea; headaches; dizziness; weakness; and injection site pain. The patient did not receive any treatment for the reported events. The outcome of the events was recovering. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1018592
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: substantial leakage of fluid (she presumes vaccine) from her injection site (no just a drop of liquid BUT a trail of fluid down her arm that wet her sweater); substantial leakage of fluid (she presumes vaccine) from her injection site (no just a drop of liquid BUT a trail of fluid down her arm that wet her sweater); This is a spontaneous report from a contactable physician. A female patient of an unspecified age received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that, when she received the vaccine, she noticed that there was a substantial leakage of fluid (she presumes vaccine) from her injection site, not just a drop of liquid, but a trail of fluid down her arm that wet her sweater. The reporting physician asked if the patient needs to assume that this qualified as a non-vaccination and needs to get a repeated dose and follow that with a true second dose in 3 weeks, or needs to assume that she got enough of a dose to call it a true first shot. The event onset date and outcome were not reported. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 1018593
Sex: F
Age:
State: IL

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: Strep test; Test Result: Positive

Allergies:

Symptoms: asthma; strep test came back positive.; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age (age: 62 unit: unspecified) received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Jan2021 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient received the first vaccine on the 12Jan, in between that time, she went to the doctor to check on her asthma, her strep test came back positive. She was on an antibiotic. The patient asked if she was able to get the second dose. On 02Feb2021, the patient was due to go back to get the vaccine. Her doctor who also provided the vaccine said that it was okay for her to get the second vaccine. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018594
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 01/06/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: covid test; Test Result: Negative ; Test Date: 20210106; Test Name: covid test; Test Result: Positive

Allergies:

Symptoms: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a non-contactable consumer or other non hcp reported for her daughter. A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 at single dose for covid-19 immunisation. Medical history included hypertension, asthma, hypersensitivity. It was unknown if the patient was pregnant at time of vaccination. Prior to vaccination the patient was not diagnosed COVID-19 positive. The patient's concomitant medications were not reported. The patient had a covid tested positive on 06Jan2021 with outcome of recovering. The patient was previously tested negative on 04Jan2021. Facility where she worked had outbreak. The events resulted in both emergency room visit and physician office visit. She was improving but her respiratory status still wasn't good. Pulmonologist just restarted 2nd round of steroids, and additional BP med started. Can now sit up but quickly gets wiped out. She was not currently hospitalized. No follow-up attempts are possible. No further information is expected. Batch/Lot numbers can not be obtained.

Other Meds:

Current Illness:

ID: 1018596
Sex: F
Age:
State: GA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: throwing up/vomiting; got very sick; This is a spontaneous report from a contactable consumer. An 88-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 21Jan2021 to 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient reported that she was taking unspecified concomitant medications. On 21Jan2021 at 11:30, the patient got very sick, throwing up/vomiting and it lasted about 3 and a half hours until 3 or 3:30 or 4. The patient took Zofran to s top throwing up. The outcome oft he events was recovered on21Jan2021. The next dose is scheduled on 11Feb2021. Information about lot and batch number was requested.

Other Meds:

Current Illness:

ID: 1018597
Sex: F
Age:
State: ME

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills, rigors; This is a spontaneous report from a non-contactable physician reported for herself. A 29-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3246), intramuscularly on left arm on 04Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient previously received her first dose of BNT162B2 on 18Dec2020 for COVID-19 immunization (lot number=EK5730; administrator route=Intramuscular, vaccine location=Right arm). The patient experienced Fever, chills, rigors occurred approximately 10 hours after vaccine administration and lasted about 6 hours on 04Jan2021. Events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was recovered in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1018598
Sex: F
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen lymph noted above the clavicular line on the right (covid shot on right arm) noted after a day i got the covid 19 vaccine; This is a spontaneous report from a contactable nurse reported for herself. A 38-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, lot unknown: true, lot unknown reason: unable to locate or read the details) intramuscularly at right arm on 08Jan2021 at 07:30 AM at a single dose for COVID-19 immunization. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, lot unknown: false) intramuscularly at right arm on 20Dec2020 at 11:30 AM at a single dose for COVID-19 immunization. No allergies to medications, food, or other products.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was at hospital. The patient was not pregnant at the time of vaccination. The patient experienced adverse events included swollen lymph noted above the clavicular line on the right (covid shot on right arm) noted after a day she got the covid 19 vaccine. She still could feel it at the reporting time. The event start date was reported on 09Jan2021 at 12:00 PM. The event was reported as non-serious. No treatment received for event. The outcome of event was not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018600
Sex: F
Age:
State: NC

Vax Date: 01/15/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left arm has a patch of discoloration; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 15Jan2021 at 09:00 (at the age of 33-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was not allergic to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 22Jan2021, the patient's left arm had a patch of discoloration which appeared approximately one week after the vaccination. The patient did not receive treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of "left arm has a patch of discoloration" was unknown.

Other Meds:

Current Illness:

ID: 1018601
Sex: F
Age:
State: MO

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on neck; This is a spontaneous report from a contactable other healthcare professional (patient). A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248), via an unspecified route of administration on 21Jan2021 at a single dose on right arm for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. No allergies to medications, food, or other products. There were no concomitant medications. The patient previously received first dose of BNT162B2 on 29Dec2020 for COVID-19 immunization (brand: Pfizer, lot number: EL1284, administration time: 02:45 PM, route: intramuscular, vaccine location: left arm, dose number: 1). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on neck on 23Jan2021 09:00. The event was reported as non-serious. The patient has not been tested for COVID since the vaccination. No treatment was received for the adverse event. The patient has not recovered from the event.

Other Meds:

Current Illness:

ID: 1018602
Sex: M
Age:
State: NJ

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210125; Test Name: blood pressure; Result Unstructured Data: Test Result:135/75; Test Date: 20210125; Test Name: temp; Result Unstructured Data: Test Result:37.1 Centigrade

Allergies:

Symptoms: temp 37.1C; blood pressure 135/75; right part of the neck stiff; cannot open mouth big; headache was worse, especially when turning the head; This is a spontaneous report from a contactable consumer reported for himself. A 74-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL8982) on 20Jan2021 at 13:00 at single dose in left arm for covid-19 immunisation. Medical history included high blood pressure. No allergies to medications, food, or other products. Concomitant medication included febuxostat (FEBUXOSTAT), benazepril hydrochloride/hydrochlorothiazide (BENAZEPRIL/HCTZ), finasteride and tamsulosin. On 21Jan2021 in the evening at 20:00 (reported as second day after vaccine) the patient experienced right part of the neck stiff and cannot open mouth big; on 22Jan2021 (reported as the third day after vaccine) headache was worse, especially when turning the head (headache started on an unspecified date in Jan2021); on 23Jan2021, 24Jan2021 and 25Jan2021 kept having headache, neck was still stiff; on 25Jan2021 temp was 37.1C and blood pressure 135/75. Events required office/clinic visit. The events were all non serious. It was unknown if treatment was given; the final outcome of all the events was not recovered.

Other Meds: FEBUXOSTAT; BENAZEPRIL/HCTZ; FINASTERIDE; TAMSULOSIN

Current Illness:

ID: 1018604
Sex: F
Age:
State: NC

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: "pins-and-needles" sensation down to the elbow/sensation was identical to a limb that is "asleep"/including the painful jolts whenever touched; Random several-inch-long patches of the arm were completely numb to physical sensation, mostly on the forearm; soreness to touch or movement of the entire upper arm inclusive of the shoulder; soreness to touch or movement of the entire upper arm inclusive of the shoulder; The soreness aside from the injection site did not abate; This is a spontaneous report received from a contactable consumer (the patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL3247), via an unspecified route of administration in the upper left arm on 21Jan2021 14:10 (at the age of 31-years-old) as a single dose for COVID-19 immunization. The patient's medical history included allergies to corn (zein). The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ibuprofen on 16Jan2021. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received the vaccine around 14:10 (scheduled for 14:00 but there was a line). Upon standing (21Jan2021 14:15), there was a "pins-and-needles" sensation down to the elbow, and by the time seated for the 15 minute wait, the sensation was present in the whole arm. The sensation was identical to a limb that was "asleep", including the painful jolts whenever touched all the way to the tips of the fingers. This lasted until mid-morning 23Jan2021 (about 44 hours). Random several-inch-long patches of the arm were completely numb to physical sensation, mostly on the forearm (21Jan2021 14:15). These have shrunk but some are still present at the time of reporting. There was additional soreness to touch or movement of the entire upper arm inclusive of the shoulder (21Jan2021 14:15). The soreness aside from the injection site (21Jan2021 14:15) did not abate until late evening on 24Jan2021. The only noted adverse effects were related to physical sensation in the left arm. The patient did not receive any treatment for the events. The clinical outcome of "pins-and-needles" sensation down to the elbow/sensation was identical to a limb that is "asleep"/including the painful jolts whenever touched was recovered on 23Jan2021. The clinical outcome of random several-inch-long patches of the arm were completely numb to physical sensation, mostly on the forearm; soreness to touch or movement of the entire upper arm inclusive of the shoulder; and soreness aside from the injection site, was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: IBUPROFEN

Current Illness:

ID: 1018605
Sex: M
Age:
State: OH

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Threw up 3 days after getting the COVID 19 vaccine; Feeling unwell; Having pain in his private area; This is a spontaneous report from a contactable consumer (patient's caregiver). This 59-year-old male patient the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 22Jan2021 at a single dose on the left arm for COVID-19 immunisation. The patient was disabled. No additional medical history was provided. No relevant concomitant medications were provided. On 25Jan2021 (3 days after getting the COVID-19 vaccine), the patient threwup, once. After vaccine, the patient was feeling unwell and he was having pain in his private area. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018607
Sex: F
Age:
State: OH

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: blood sugar; Result Unstructured Data: Test Result:within normal limits; Test Date: 20210121; Test Name: Blood pressure; Result Unstructured Data: Test Result:155/94; Comments: up; Test Date: 20210121; Test Name: temperature; Result Unstructured Data: Test Result:within normal limits; Test Date: 20210121; Test Name: pulse rate; Result Unstructured Data: Test Result:up

Allergies:

Symptoms: Face and chest became bright red; felt very hot; sinus pressure increased; blood pressure was up 155/94; pulse rate up; This is a spontaneous report received from a contactable consumer (the patient). A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL 9261), via an unspecified route of administration in the left arm on 21Jan2021 15:45 (at the age of 65-years-old) as a single dose for COVID-19 immunization. The patient's medical history included high cholesterol, indoor and outdoor allergies, and allergies to latex and contrast. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient previously took and had allergies to: amoxicillin/ clavulanic acid (AUGMENTIN), sulfamethoxazole/ trimethoprim (BACTRIM), levofloxacin (LEVAQUIN), and gabapentin. The patient did not receive any other vaccines within four weeks prior to the vaccination. Within 5 minutes of receiving the dose on 21Jan2021, at 15:45 (as reported), the patient's face and chest became bright red, felt very hot, sinus pressure increased. The EMT's took her blood pressure- was up 155/94, and her pulse rate was up (21Jan2021, 15:45 (as reported)). Her temperature and blood sugar were within normal limits (21Jan2021). The patient did not receive any treatment for the events. The clinical outcome of face and chest became bright red, felt very hot, sinus pressure increased, blood pressure was up 155/94, and pulse rate up was recovered on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1018608
Sex: M
Age:
State: NY

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: the injection site started to inch and it got a red blotch about 2 inches in diameter; the injection site started to inch and it got a red blotch about 2 inches in diameter; soreness; This is a spontaneous report from a contactable consumer reported for himself. A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247) via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. Medical history included idiopathic thrombocytopenic purpura (ITP). Concomitant medications included romiplostim (NPLATE) for ITP. The patient stated he received his first dose of the vaccine on 15Jan2021, some soreness on 15Jan2021 afterwards but nothing that noticeable and about a week later on the 22Jan2021, the injection site started to inch and it got a red blotch about 2 inches in diameter. Just about it started a week after the injection. So, he was wondering if that was to be expected or was it unusual or how he should proceed. The events were reported as non-serious. No treatment received for events. Due date for the next shot was 05Feb2021. The outcome of event the injection site started to inch and it got a red blotch about 2 inches in diameter was not resolved, and of soreness was unknown.

Other Meds: NPLATE

Current Illness:

ID: 1018609
Sex: F
Age:
State: NJ

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: warm sensation; anxiety; sore arm; This is a spontaneous report from a contactable consumer, reporting for herself. A 44-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration at the right arm on 23Jan2021 17:15 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. On 23Jan2021 17:30, the patient experienced warm sensation, anxiety and sore arm. No treatment was received. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on an unspecified date. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1018611
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild pain on the injection site/my arm hurt just a little bit; This is a spontaneous report from a contactable consumer (patient). This consumer reported same event for herself and her husband. This is the first of the two reports. An elderly female patient above 75 years old received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the arm, on an unspecified date at single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. After the first vaccination, patient experienced very mild pain on the injection site that went away the next day, patient's arm hurt just a little bit, but by the next day was fine. Patient took an acetylsalicylic acid (BABY ASPIRIN) and did not experience hematoma/bleeding on the injection site. The patient has been told that some friends experienced a higher incidence/severity of adverse events after the 2nd dose (including pain on the injection site, fever, chills, vomiting) (AER#2021092618). Patient is about to receive their 2nd dose 21 days later (this Friday). She is wondering if the diphenhydramine hydrochloride/paracetamol (TYLENOL PM) and aspirin will affect the vaccine-induced antibody response and if it is true that patients get 'sicker' after the 2nd dose. (Is the incidence of AEs higher after the 2nd dose?). She is referring to the Pfizer-BioNTech COVID-19 vaccine. Outcome of the event was recovered. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021092617 same product/event, different patient.

Other Meds:

Current Illness:

ID: 1018612
Sex: M
Age:
State: NC

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210125; Test Name: fever; Result Unstructured Data: Test Result:101.5.

Allergies:

Symptoms: arms were sore; feels unwell; Tiredness; chills; this morning about 8 am I was running a fever 101.5; muscle ache; joint pain/joint aches; severe injection site pain; swelling and redness in left arm at injection site; swelling and redness in left arm at injection site; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiration date listed on the card was either 03May2021 or 31May2021), intramuscularly in left arm on 24Jan2021 13:30 at 0.3 ml single for COVID-19 immunization. Medical history included COVID from Jun2020. Concomitant medications were none. Patient received the first dose of the vaccine, initially before bed he noticed his arms were sore, about 2 a.m., his arm was so sore it woke him up when he rolled over on it. It hurt throughout the night, he started to get chills, just like when he had COVID earlier in the year and this morning about 8 a.m. he was running a fever 101.5, muscle ache and joint pain. He felt exactly how he felt, when running a fever. He was experiencing 8 of the 12 side effects, none of the allergic reactions only fever, joint aches. He was experiencing about 90% of the side effects listed on page 3 the paperwork he received. He was not having any breathing issues. He had severe injection site pain on 24Jan2021, it literally felt like he had surgery on his left arm. Since he woke up this morning around 6 a.m. he had been experiencing tiredness, muscle pain, chills, joint pain, and he had a fever of 101.5 all on 25Jan2021. He had swelling and redness in his left arm at injection site on 24Jan2021. He didn't feel any lymph node swelling and he was not sick. He felt unwell. He felt like he twisted his shoulder, he went to bed and he woke up shivering like he had the COVID virus. He had the COVID virus back in Jun2020. The injection site arm pain was severe in the middle of night, and woke him up in the middle of the night. When he rolled over, he explained that he used both arms to help get out of bed and he could barely get up to go to the restroom. He was wrapped up so the chills were pretty good, when he woke up they were racking chills (which he also experienced these type of chills when he had the COVID virus). No treatment was received. He needed a magnifying glass and to get in the light to see the lot number on the card he was given. He took a boatload of drugs. Reported the details about his medications could be obtained from this hcp. He did not know them off the top of his head. Outcome of events arms were sore and felt unwell was unknown and of other events was not resolved.

Other Meds:

Current Illness:

ID: 1018614
Sex: F
Age:
State: PA

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: very flushed; perspiring; Feeling hot; Red face; chills; This is a spontaneous report from a contactable pharmacist reporting for herself. A 43-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacture Pfizer-BioNTech, lot# EL3249), via an unspecified route of administration, on 24Jan2021 at 14:30, at single dose, for COVID-19 immunisation. Medical history included endometriosis and migraine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included ibuprofen (MOTRIN) and unspecified oral contraceptives. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EL1284), on 04Jan2021 at 01:00 PM, in left arm, for COVID-19 immunisation. The patient experienced very flushed, perspiring, feeling hot, red face and chills all on 24Jan2021 at 15:00 with outcome of recovered after about 1 hour. Since the vaccination the patient has not been tested for COVID-19.

Other Meds: MOTRIN [IBUPROFEN]

Current Illness:

ID: 1018615
Sex: F
Age:
State: TX

Vax Date: 01/22/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:97.2; Comments: usually; Test Date: 20210124; Test Name: temperature; Result Unstructured Data: Test Result:98.9; Comments: went up

Allergies:

Symptoms: dizziness; burning tongue, mouth, and lips; burning tongue, mouth, and lips; sinus pressure; no ability to smell or taste; no ability to smell or taste; bitter taste; sense of being poisoned or given some horrible drug; temperature went up to 98.9; EXTREME fatigue; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1283), via an unspecified route of administration on 22Jan2021 10:45 at single dose on left arm for covid-19 immunisation. Medical history included known allergies: sulfa, hypo thyroid, hypogammaglobulinemia, arthritis and hypertension. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included losartan, carvedilol, methylphenidate hydrochloride (RITALIN), potassium and unspecific thyroid medication. It was reported that second day after vaccination (24Jan2021), patient experienced extreme fatigue. Third day after vaccination (25Jan2021) patient experienced extreme fatigue, dizziness, burning tongue, mouth, and lips, sinus pressure, no ability to smell or taste except a bitter taste, sense of being poisoned or given some horrible drug, temperature went up to 98.9 - which is high for patient. Patient was usually 97.2. On fourth day of vaccination (26Jan2021): patient was fine. Totally back to normal. No treatment was received. The events resulted doctor or other healthcare professional office/clinic visit. This case was reported as non-serious. All events were resolved on 26Jan2021.

Other Meds: LOSARTAN; CARVEDILOL; RITALIN; POTASSIUM

Current Illness:

ID: 1018617
Sex: F
Age:
State: KY

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizzy; Unbalanced when attempting to walk; Blurry vision; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9262; Expiration date was not reported) on 23Jan2021 (12:30) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the school or student health clinic. The patient had no relevant medical history. The patient had unspecified concomitant medications. The patient was not pregnant at the time of vaccination. On 24Jan2021 (21:00), the patient was dizzy; unbalanced when attempting to walk; and had blurry vision. It was unknown if the patient had received treatment for the reported events. The outcome of the events, 'dizzy', 'unbalanced when attempting to walk' and 'blurry vision', was not recovered. The patient was not diagnosed with COVID-19 prior to the vaccination, and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1018618
Sex: M
Age:
State: SC

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: heart rate; Result Unstructured Data: Test Result:increased

Allergies:

Symptoms: Shortness of breath; palpitations/increased heart rate; palpitations/increased heart rate; Immediate left arm/chest pain; Immediate left arm/chest pain; fatigue; body aches; This is a spontaneous report from a contactable physician. A 47-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3246), via intramuscular, on 18Jan2021 at single dose on the left arm for COVID-19 immunisation, administered at Hospital. The patient did not have a relevant medical history. No known allergies. No relevant concomitant medications were provided. No other vaccine was received in four weeks. The patient developed immediate left arm/chest pain, and fatigue/body aches. On 23Jan2021 (5 days later), he developed shortness of breath and palpitations/increased heart rate. Post-vaccination COVID test was not performed. The patient was not treated for the events. The patient was recovering from the events.

Other Meds:

Current Illness:

ID: 1018619
Sex: M
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: looks like a cold, dizzy, slight fever, feels weakness; looks like a cold, dizzy, slight fever, feels weakness; looks like a cold, dizzy, slight fever, feels weakness; looks like a cold, dizzy, slight fever, feels weakness; I feel not so good; cough; positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer reported for himself. A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot# EK9231 on 11Jan2021 at single dose for COVID-19 immunization. The second dose of vaccine was scheduled on 02Feb2021. The patient had no medical history. Concomitant medications were not reported. Beginning on Friday, 22Jan2021, he started having symptoms that "looks like a cold, dizzy, slight fever, feels weakness", "I feel not so good" and cough. On unknown date in Jan2021 the patient was positive to SARS-CoV-2 test. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1018621
Sex: F
Age:
State: IL

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: Body Temperature; Result Unstructured Data: Test Result:102 degrees fahrenheit; Comments: 'as high as 102 degrees Fahrenheit'

Allergies:

Symptoms: Fever/fever that has been as high as 102 degrees Fahrenheit; Terrible headache; Achy; Stuffy nose; Sleep-she slept almost the whole weekend; This is a spontaneous report from a contactable consumer, the patient. A 59-years-old female patient (consumer) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3249, Expiration Date May2021), via an unspecified route of administration 0.3mL injection to right arm on 22Jan2021 at 15:45 as a single dose, for COVID-19 vaccination. The vaccination was administered at a Hospital. Medical History includes Severe allergic reaction to bee sting (At 14 years of age, stepped on a beehive received 50+ bee stings. Had to use an Epi-pen in response to this possible severe allergic reaction to bees) There were no concomitant medications. No other vaccines were given within 4 weeks. On 23Jan2021 at 08:00 , the patient experienced Terrible side effects, fever that has been as high as 102 degrees fahrenheit; terrible headache; achy; stuffy nose; and sleep-she slept almost the whole weekend. The patient underwent lab tests which included body temperature: 'as high as 102 degrees Fahrenheit' on 23Jan2021. Fever has come down but she still has one. Consumer had no physician office visits, no emergency room visits and no hospitalizations were involved. Caller inquired how long do the side effects generally last, should she get the second dose of the vaccine and should she have a COVID test before she goes back to work? The patient's second dose was scheduled for 12Feb2021 but no dose change made at this time. The clinical outcome of the event fever was recovering, while headache, achy, stuffy nose, slept most of the weekend was unknown .

Other Meds:

Current Illness:

ID: 1018622
Sex: M
Age:
State: VA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210120; Test Name: body temp; Result Unstructured Data: Test Result:101.5; Comments: fever; Test Date: 20210123; Test Name: BinaxNow/Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Muscle pain; fatigue; Headache; diarrhea; Fever 101.5; This is a spontaneous report from a non-contactable pharmacist reporting for himself. A 42-year-old male patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at right arm on 20Jan2021 02:00 PM at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient previously received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at left arm at 42 years old on Dec2020 03:00 PM for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications received within 2 weeks of vaccination. The patient experienced muscle pain, fatigue, headache, diarrhea, fever 101.5; all on 20Jan2021 06:00 PM. The patient required 12 hours in bed to recover. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had Covid test post_vaccination (Nasal Swab,Bi naxNow) on 23Jan2021 with negative result. Outcome of the events was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018624
Sex: F
Age:
State: TN

Vax Date: 01/02/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash on my elbow; loss of appetite; tired; dizzy; This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Jan2021 10:00 on Arm left at single dose (Lot # EL3246) for covid-19 immunisation. No medical history and concomitant therapy. She woke feeling dizzy on 24Jan2021, went to bed feeling dizzy and woke up feeling dizzy and the feeling isn't going away and she has a rash on her elbow on 25Jan2021. She took an antihistamine for it. She took the (Pharmacy name) off brand antihistamine. She does not know the name of it. She doesn't have an appetite on 25Jan2021. She doesn't feel sick but she usually loves her breakfast. She also maybe is a little tired on 25Jan2021. She also reports that her second vaccine dose is due today and feeling like this she doesn't know if she should get it. Outcome of the event dizzy was not recovered. Outcome of other events was unknown.

Other Meds:

Current Illness:

ID: 1018625
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very deep muscle pain, that kind of comes and goes; Joint pain, it's like just deep and very achy as opposed to like any kind of shooting pain; Joint pain, it's like just deep and very achy as opposed to like any kind of shooting pain; This is a spontaneous report from a contactable consumer, reporting for herself. A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 (at the age of 71 years old) as a single dose for COVID-19 vaccination. Medical history was not reported. Concomitant medications were not reported, but she was taking other medications. On 23Jan2021, the patient experienced very deep muscle pain, that kind of comes and goes. On an unspecified date in Jan2021, the patient experienced joint pain, it's like just deep and very achy as opposed to like any kind of shooting pain. The patient received treatment for the events, which included ice pack, Tiger Balm, and ibuprofen 600mg . The clinical outcome of muscle pain was not recovered, and for joint pain and ache was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018626
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headaches; arm hurt a lot; I don't feel very well; My eyes are bothering me; This is a spontaneous report from a contactable consumer, reporting for herself. A 65-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date in Jan2021 at 20:30 (at the age of 65 years old) as a single dose for COVID-19 vaccination. Medical history included being diabetic from an unspecified date. Concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced headaches, arm hurt a lot, don't feel very well, and her eyes are bothering her. The clinical outcome of headaches, arm hurt a lot, don't feel very well, and her eyes are bothering her was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018628
Sex: M
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; Stomach discomfort/bowel discomfort; This is a spontaneous report from a contactable consumer reporting for himself. This 20-year-old male patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on unknown date at a single dose on the left arm for COVID-19 immunisation. No other vaccine was received in four weeks. Relevant medical history included postural orthostatic tachycardia syndrome. No relevant concomitant medications were provided. On unknown date, after vaccination, the patient developed nausea and stomach discomfort/bowel discomfort. The patient was not treated for the events. Pre-vaccination and post-vaccination COVID tests were not performed. The patient was recovering from the events. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018629
Sex: F
Age:
State: DC

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210124; Test Name: Rapid Antigen; Result Unstructured Data: Test Result:Pending

Allergies:

Symptoms: constant fluctuation of burning up; sweating profusely; having chills; headache; diarrhea; dryness of mouth; runny nose; occasional coughing; dizziness; occasional fatigue; This is a spontaneous report from a contactable consumer reporting for herself. A 29-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from 21Jan2021 09:00 (at the age of 29-years-old) at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included spironolactone, sertraline and bupropion. Prior to vaccination the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital. On 22Jan2021 11:00, the patient experienced constant fluctuation of burning up, sweating profusely, having chills, headache, diarrhea, dryness of mouth, runny nose, occasional coughing, dizziness and occasional fatigue. No treatment was received for the events. The events were reported as non-serious. The patient underwent lab tests and procedures which included Rapid Antigen: pending on 24Jan2021. Outcome of the constant fluctuation of burning up, sweating profusely, having chills, headache, diarrhea, dryness of mouth, runny nose, occasional coughing, dizziness and occasional fatigue was not recovered. Since the vaccination, the patient been tested for COVID-19.

Other Meds: SPIRONOLACTONE; SERTRALINE; BUPROPION

Current Illness:

ID: 1018631
Sex: F
Age:
State: WI

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Slight soreness in arm; This is a spontaneous report from a contactable consumer reporting for herself. A 75-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261), via an unspecified route of administration on 22Jan2021 14:45 at single dose for covid-19 immunisation. Medical history included breast cancer from 2016 to 2016. The patient's concomitant medications were not reported. The patient experienced Slight soreness in arm. Outcome of event was unknown.

Other Meds:

Current Illness:

ID: 1018632
Sex: M
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vomited; felt sick; very loose stool; fever; felt like beat with baseball bat; body aches; muscle joints hurt; flu like symptoms; head pounding; this may have been a bad batch or something; This is a spontaneous report from a contactable consumer. A 59-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EL3302 , via an unspecified route of administration on 22Jan2021 10:00 (at the age of 59-years-old) as a SINGLE DOSE in the left arm for COVID-19 vaccination. Medical history included potentially had Covid prior to receiving the vaccine from an unknown date and unknown if ongoing, he had antibodies prior to the vaccine from an unknown date and unknown if ongoing. The consumer reported he must have had Covid in the Spring because he got sick, took a Sudafed and had Afrin nose spray and was fine after that. The patient previously took pseudoephedrine hydrochloride (SUDAFED) for he got sick, oxymetazoline hydrochloride (AFRIN) nasal decongestant for he got sick. They were giving shots out to the military. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 23Jan2021, the patient experienced flu like symptoms, body aches, head pounding, muscle joints hurt, felt sick, fever, felt like beat with baseball bat, vomited, very loose stool. The consumer reported that this may have been a bad batch or something in Jan2021. The consumer reported that the body aches started at 8AM and resolved at 6PM. The consumer reported that he recovered from all other events late afternoon on Saturday. The consumer reported he vomited from noon-1PM. The consumer reportedhad body aches at 08:00, muscle joints hurt at 08:00, felt like he was beat with a baseball bat 08:00, felt sick at 10:00, vomited 12:00, loose stool 09:00 and fever 08:00 .The events did not require a visit to the emergency room or physician office. No treatment was received for the events. Outcome of the events flu like symptoms, body aches, head pounding, muscle joints hurt, felt sick, fever, felt like beat with baseball bat, vomited, very loose stool was recovered on 23Jan2021. Outcome of the event this may have been a bad batch or something was unknown.

Other Meds:

Current Illness:

ID: 1018633
Sex: M
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swollen lymph node under my armpit on the same side of the injection; This is a spontaneous report from a contactable consumer(patient). A male patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swollen lymph node under his armpit on the same side of the injection on 22Jan2021. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1018635
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 01/07/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: COVID 19 Test; Test Result: Positive ; Comments: tested positive for COVID-19 on 07Jan2021

Allergies:

Symptoms: infected by covid on 07Jan; infected by covid on 07Jan; This is a spontaneous report from a contactable Other Health Professional (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was infected by covid on 07Jan2021 and tested positive for COVID-19 on 07Jan2021. She was given Zanamivir (was not able to verify) on 12Jan2021, started with Bamlanivimab antibodies treatment on 12Jan2021 and has fully recovered from COVID in Jan2021 since then as it was a mild form only. The patient would like to get the second dose as soon as possible, second dose of the vaccine was scheduled for 12Jan2021. She is looking on guidance on pursuing the second dose of the vaccine. Serious: No. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 test positive and drug ineffective due to temporal relationship. This case will be reassessed once additional information is available.

Other Meds:

Current Illness:

ID: 1018636
Sex: F
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash/ugly rash; itchy rash; This is a spontaneous report from a contactable consumer (patient). This 80-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 13Jan2021 for COVID-19 immunisation. Medical history included patient was allergic to a lot of medication. Concomitant medication was not reported. Patient received 1st dose of vaccine on 13Jan2021. On 20Jan2021, the patient developed a rash: got red, breaks down to smaller rash, itchy rash, "ugly rash". Patient said she had not added any new products to her diet and no changes in her life. Patient said she was allergic to a lot of medication, and she got rashes all the time. Patient said she had not had fever, shortness of breath or difficulty breathing. Only rash reported. Patient was asking if the rash could be from the vaccine since it didn't start "right after" getting her dose. It was made patient aware that some of the other reported experiences after vaccine were reported within 7 days of dose; made patient aware there was no way to confirm or deny if her rash was from vaccine. Referred patient to speak with HCP. Patient was inquiring about getting 2nd dose of vaccine after experiencing side effect after 1 dose. Patient had already spoken with her PCP, who encouraged the 2nd dose. It was referred patient to speak with HCP before making any medical decisions; made patient aware the only contraindication at this time, to getting doses would be severe allergic reaction to ingredients/1st dose. The outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018638
Sex: F
Age:
State: AZ

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Muscle and joint ache; Muscle and joint ache; Headache; Injection site pain; Tingling; Numbness; Muscle weakness; Swelling and pain in left arm; Swelling and pain in left arm - all the way down to hand; Swelling and pain in left arm - all the way down to hand; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Lot. EL3248) at single dose, in the left arm, on 21Jan2021, at 11:45 AM, for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Relevant medical history included allergies to sulfa drugs and to wasps, fibromyalgia (autoimmune issues), rosacea, rheumatoid arthritis (RA) and frozen shoulder (L). Concomitant medications, received within 2 weeks of vaccination, included cannabidiol (CBD OIL), vitamin D (ergocalciferol), biotin and meloxicam (MEL). On 21Jan2021, at 03:00 PM, the patient experienced chills, muscle and joint aches, headache, injection site pain, tingling and numbness, muscle weakness, swelling and pain in left arm - all the way down to hand. No treatment was received. The patient did not recover from the events at time of this report. The case was assessed as non-serious (seriousness criteria-results in death: no, seriousness criteria-life threatening: no, seriousness criteria-caused/prolonged hospitalization: no, seriousness criteria-disabling/incapacitating: no and seriousness criteria-congenital anomaly/birth defect: no). Post the vaccination, the patient has not been tested for COVID-19.

Other Meds: CBD OIL; VITAMIN D [ERGOCALCIFEROL]; BIOTIN; MEL

Current Illness:

ID: 1018639
Sex: F
Age:
State: TX

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Fever; Injection site swelling; Injection site redness; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH 9899), via an unspecified route of administration on 21Dec2020 09:00 at a single dose for COVID-19 immunization. The patient's medical history included achondroplasia. The patient have no known allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Concomitant medication included drospirenone, ethinylestradiol betadex clathrate (YAZ). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 21Dec2020, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, and feeling unwell. Outcome of the events was recovered. The events were considered non-serious.

Other Meds: YAZ

Current Illness:

ID: 1018641
Sex: F
Age:
State: AZ

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: Fever; Result Unstructured Data: Test Result:102.8; Comments: Highest

Allergies:

Symptoms: Fever (highest 102..8); Body aches; Chills; This is a spontaneous report from a contactable Pharmacist, the patient. This 39-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EL1283), via an unspecified route of administration in the left arm on 22Jan2021 at 09:15 (at the age of 39-years-old) as a single dose for COVID-19 vaccination. Medical history included seasonal allergies from an unknown date and unknown if ongoing. Concomitant medication included ibuprofen (IBUPROFEN) and fexofenadine (FEXOFENADINE). The patient previously received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number: EL1284), dose #1, via an unspecified route of administration in the left arm on 30Dec2020 as a single dose for COVID-19 vaccination. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 23Jan2021 at 01:00, the patient experienced fever (highest 102.8), body aches and chills. Therapeutic measures taken included ibuprofen to reduce the fever. The clinical outcomes of the fever (highest (102.8), body aches and chills were resolved on an unspecified date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: IBUPROFEN; FEXOFENADINE

Current Illness:

ID: 1018642
Sex: F
Age:
State: HI

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diarrhea; This is a spontaneous report from a contactable 36-year-old female healthcare professional reported for herself that she received bnt162b2 (BNT162B2) on 23Jan2021 02:45 PM for COVID-19 immunization Medical history was not provided. Patient was not diagnosed with COVID-19 prior to vaccination. Patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Concomitant drugs were reported as none. The patient experienced diarrhea on 24Jan2021. Event was reported non-serious and no treatment was received for it. The patient has not tested for COVID-19. Outcome of the event was resolving. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm